Eric Whitman, MD, medical director of Atlantic Health System Cancer Care, Atlantic Health System, discusses ways to expand the benefit of immunotherapy in non-immunogenic solid tumors.
Eric Whitman, MD
Advertisement
Articles by Eric Whitman, MD
Eric Whitman, MD, medical director of Atlantic Health System Cancer Care, Atlantic Health System, discusses eliminating financial toxicity in oncology.
Eric Whitman, MD, medical director of Atlantic Health System Cancer Care, Atlantic Health System, discusses improving precision medicine in oncology.
Eric Whitman, MD, medical director of Atlantic Health System Cancer Care, Atlantic Health System, discusses the partnership between Atlantic Health System, Translational Genomics Research Institute (TGen), and Origin Commercial Ventures.
Eric Whitman, MD, surgeon, Atlantic Health System, discusses the role of pembrolizumab (Keytruda) in the treatment of patients with melanoma.
Advertisement
Latest Updated Articles
Dr. Whitman on the Role of Pembrolizumab in MelanomaPublished: March 15th 2018 | Updated:
Dr. Whitman on the Partnership Between Atlantic Health System, TGen and OriginPublished: October 5th 2018 | Updated:
Dr. Whitman on Improving Precision Medicine in OncologyPublished: October 10th 2018 | Updated:
Dr. Whitman on Eliminating Financial Toxicity in OncologyPublished: October 17th 2018 | Updated:
Dr. Whitman on Expanding the Benefit of Immunotherapy in Solid TumorsPublished: May 17th 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5